BioForce Nanosciences Holdings, Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported net loss was USD 0.11386 million compared to USD 0.117922 million a year ago. For the nine months, net loss was USD 0.381254 million compared to USD 158.29 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 10.36 a year ago.